Application no. and date | 11153604.1 (espacenet) (Federated) (European Patent Register), 20050816 | Patent/reg. no. and date | DK/EP 2319925, 20180725 | Publication date | 20110511 | Priority no. and date | EP 04019405, 20040816, US 601983 P, 20040817, US 604668 P, 20040825, US 609786 P, 20040914, US 638659 P, 20041222, US 664236 P, 20050322, US 688943 P, 20050608 | EP pub. no. and date |
EP 2319925 20110511 | Effective date | | Applicant/owner | Quark Pharmaceuticals, Inc., 6501 Dumbarton Circle
Fremont, California 94555, US, Silence Therapeutics Aktiengesellschaft, Robert-Rössle-Strasse 10
13125 Berlin, DE | Applicant ref. no. | V1808-018-DK | Inventor | FEINSTEIN, Elena, 13/55 HaCarmel Street
76305 Rehovot, IL, Kaufmann, Jörg, c/o Silence Therapeutics AG Robert-Rössle-Strasse 10
13125 Berlin, DE, Giese, Klaus, c/o Silence Therapeutics AG Robert-Rössle-Strasse 10
13125 Berlin, DE | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/713 (2006.01) , C12N 15/113 (2010.01) , A61P 11/00 (2006.01) , A61P 27/00 (2006.01) | Title | Terapeutiske anvendelser af RTP801-hæmmere | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|